1802408-28-1 Usage
Uses
Used in Pharmaceutical Industry:
(-)-10-chloro-9-(3-methoxypropoxy)-6-(1-methylcyclopropyl)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid is used as a potential pharmaceutical compound for its possible bioactivity. The cyclic structure and carboxylic acid group are common features in bioactive molecules, which may contribute to its potential therapeutic effects.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (-)-10-chloro-9-(3-methoxypropoxy)-6-(1-methylcyclopropyl)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid serves as a subject for further testing and analysis. Researchers may investigate its interactions with biological targets, its pharmacokinetics, and its safety profile to assess its suitability as a drug candidate.
Check Digit Verification of cas no
The CAS Registry Mumber 1802408-28-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,0,2,4,0 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1802408-28:
(9*1)+(8*8)+(7*0)+(6*2)+(5*4)+(4*0)+(3*8)+(2*2)+(1*8)=141
141 % 10 = 1
So 1802408-28-1 is a valid CAS Registry Number.
1802408-28-1Relevant academic research and scientific papers
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
-
, (2015/08/04)
The invention provides novel compounds having the general formula: wherein R1, R2, R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds.
NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
-
, (2015/09/23)
The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.
